Writer and Editor : Canaya Vania Rehansha

Depok, January 2026 : PT Biometrik Riset Indonesia extends its warmest wishes for a Happy New Year 2026 to all partners, clients, and stakeholders. The beginning of a new year marks an important moment for reflection as well as renewed commitment to delivering high-quality bioavailability and bioequivalence (BA/BE) studies for the pharmaceutical industry.

Reflecting on the Previous Year

Throughout 2025, PT Biometrik Riset Indonesia continued to actively support pharmaceutical companies through the execution of various BA/BE studies. The trust placed in us by both local and international sponsors has been a strong motivation to continuously improve our capabilities, operational systems, and overall service quality.

These achievements would not have been possible without close collaboration with our partners, regulators, and the dedication of our internal teams who consistently uphold professional and regulatory standards.

Focus and Commitment in 2026

In 2026, PT Biometrik Riset Indonesia remains focused on strengthening service consistency, regulatory compliance, and operational reliability across all BA/BE activities. Through continuous improvement and close collaboration with our partners, we are committed to delivering dependable support that meets industry and regulatory expectations.

Moving Forward Together

PT Biometrik Riset Indonesia believes that sustainable success is built on strong partnerships, open communication, and a firm commitment to quality. We look forward to strengthening existing collaborations and creating new opportunities together in 2026.

Once again, Happy New Year 2026. May this year bring continued growth, success, and mutual achievement.